A novel BRCA2 gene mutation, 4081 insA, in a Finnish breast/ovarian cancer family associated with favourable clinical course

A novel BRCA2 gene mutation, 4081 insA, in a Finnish breast/ovarian cancer family associated with favourable clinical course

Bibliographic Details
Main Authors: Hartikainen, J, Kataja, V, Mannermaa, A
Format: Online
Language:English
Published: BioMed Central 2000
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300896/
id pubmed-3300896
recordtype oai_dc
spelling pubmed-33008962012-03-14 A novel BRCA2 gene mutation, 4081 insA, in a Finnish breast/ovarian cancer family associated with favourable clinical course Hartikainen, J Kataja, V Mannermaa, A Meeting Abstract BioMed Central 2000 2000-03-12 /pmc/articles/PMC3300896/ http://dx.doi.org/10.1186/bcr95 Text en Copyright ©2000 Current Science Ltd
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Hartikainen, J
Kataja, V
Mannermaa, A
spellingShingle Hartikainen, J
Kataja, V
Mannermaa, A
A novel BRCA2 gene mutation, 4081 insA, in a Finnish breast/ovarian cancer family associated with favourable clinical course
author_facet Hartikainen, J
Kataja, V
Mannermaa, A
author_sort Hartikainen, J
title A novel BRCA2 gene mutation, 4081 insA, in a Finnish breast/ovarian cancer family associated with favourable clinical course
title_short A novel BRCA2 gene mutation, 4081 insA, in a Finnish breast/ovarian cancer family associated with favourable clinical course
title_full A novel BRCA2 gene mutation, 4081 insA, in a Finnish breast/ovarian cancer family associated with favourable clinical course
title_fullStr A novel BRCA2 gene mutation, 4081 insA, in a Finnish breast/ovarian cancer family associated with favourable clinical course
title_full_unstemmed A novel BRCA2 gene mutation, 4081 insA, in a Finnish breast/ovarian cancer family associated with favourable clinical course
title_sort novel brca2 gene mutation, 4081 insa, in a finnish breast/ovarian cancer family associated with favourable clinical course
description
publisher BioMed Central
publishDate 2000
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300896/
_version_ 1611512905307521024

Similar Items